Education
About Us
Working with TipRanks
Follow Us
Surgical Innovations (GB:SUN)
LSE:SUN
Total Valuation
Surgical Innovations has a market cap or net worth of £5.13M. The enterprise value is 7.94M.
Market Cap£5.13M
Enterprise Value7.94M
Share Statistics
Surgical Innovations has 932,816,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding932,816,160
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Surgical Innovations’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -7.54%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-7.54%
Return on Capital Employed (ROCE)-0.08
Revenue Per Employee149.31K
Profits Per Employee-24.29K
Employee Count80
Asset Turnover0.98
Inventory Turnover2.87
Valuation Ratios
The current PE Ratio of Surgical Innovations is ―. Surgical Innovations’s PEG ratio is -0.00825.
PE Ratio―
PS Ratio0.43
PB Ratio0.60
Price to Fair Value0.60
Price to FCF-12.54
Price to Operating Cash Flow-69.33
PEG Ratio-0.00825
Income Statement
In the last 12 months, Surgical Innovations had revenue of 11.95M and earned -1.94M in profits. Earnings per share was 0.00.
Revenue11.95M
Gross Profit3.44M
Operating Income-791.00K
Pretax Income-2.05M
Net Income-1.94M
EBITDA-99.00K
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was 214.00K and capital expenditures -55.00K, giving a free cash flow of 159.00K billion.
Operating Cash Flow214.00K
Free Cash Flow159.00K
Free Cash Flow per Share<0.01
Dividends & Yields
Surgical Innovations pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.19
52-Week Price Change-18.18%
50-Day Moving Average0.57
200-Day Moving Average0.63
Relative Strength Index (RSI)<0.01
Average Volume (3m)179.78K
Important Dates
Surgical Innovations upcoming earnings date is Mar 19, 2026, TBA (Confirmed).
Last Earnings DateSep 29, 2025
Next Earnings DateMar 19, 2026
Ex-Dividend Date―
Financial Position
Surgical Innovations as a current ratio of 1.88, with Debt / Equity ratio of 14.52%
Current Ratio1.88
Quick Ratio0.83
Debt to Market Cap0.10
Net Debt to EBITDA-10.56
Interest Coverage Ratio-7.99
Taxes
In the past 12 months, Surgical Innovations has paid -107.00K in taxes.
Income Tax-107.00K
Effective Tax Rate0.05
Enterprise Valuation
Surgical Innovations EV to EBITDA ratio is -62.38, with an EV/FCF ratio of -15.10.
EV to Sales0.52
EV to EBITDA-62.38
EV to Free Cash Flow-15.10
EV to Operating Cash Flow-83.45
Balance Sheet
Surgical Innovations has -£461.00K in cash and marketable securities with £938.00K in debt, giving a net cash position of -£1.40M billion.
Cash & Marketable Securities-£461.00K
Total Debt£938.00K
Net Cash-£1.40M
Net Cash Per Share>-£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is 28.77%, with operating margin of -6.62%, and net profit margin of -16.27%.
Gross Margin28.77%
Operating Margin-6.62%
Pretax Margin-17.16%
Net Profit Margin-16.27%
EBITDA Margin-0.83%
EBIT Margin-16.33%
Analyst Forecast
The average price target for Surgical Innovations is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-4.98%
EPS Growth Forecast-114.29%